Women's Health

In June 2021, ibrexafungerp (Brexafemme; Scynexis) became the first drug approved by the U.S. Food and Drug Administration (FDA) in a novel antifungal class in more than 20 years and is now available to treat vulvovaginal candidiasis (VVC).

Pharmacists can improve quality of life for the women they care for by offering advice, education, and other point-of-care services.

Oteseconazole (Vivjoa) reduces the incidence of recurrent vulvovaginal candidiasis.

Data from a cohort of 5000 patients indicates that NSAID use may negatively effect clodronate therapy in older women.

Between 6% and 10% of women diagnosed with vulvovaginal candidiasis are believed to develop a recurrent form of this condition with 3 to 4 or more episodes in a single year.

Ibrexafungerp is a promising novel, well-tolerated and effective oral 1-day treatment for acute vulvovaginal candidiasis.

Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?

While the use of combined oral contraceptives in patients with rheumatoid and autoimmune disorders have focused on safety, a recent narrative review highlighted the efficacy and benefits of these contraceptives in women with RA.

A presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.

An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.

Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla) transdermal system.

The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.

Researchers evaluated the effectiveness of oral probiotics in secondary prevention of vulvovaginal infections in pregnant women.

Half of prisons and over 80% of jails in the United States allowed postpartum permanent contraception, according to a study in the journal Contraception.

Provider bias is often based on racial/ethnic, socioeconomic, and age-based assumptions.

The findings show that increased access to emergency contraception does not compromise use of other more effective methods or lead to an increase in reported levels of unprotected sexual intercourse, according to Hawkins.

Human papillomavirus (HPV) vaccination has significantly decreased the incidence and mortality of cervical cancer in girls and women between the ages of 15 and 24, according to a research letter in JAMA Pediatrics.

Take a look back at the top 10 women’s health news articles published on Drug Topics® this year.

Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.

When women are underrepresented in health care, half of our world’s population becomes at-risk.

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.

One year after the close of the Increasing Access to Contraception (IAC) Learning Community, participants had sustained their efforts in support of at least 1 goal: to improve adolescent girls' and women’s access to the full range of contraceptive options.

"The spread of misinformation and mistrust in doctors and science is contributing to staggeringly low vaccination rates among pregnant people," said the American Colleges of Obstetricians and Gynecologists.